Powered by LumidaWealth.com
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
No Result
View All Result
  • Lumida Wealth
  • Lumida Ledger
  • LUMIDA ETF
  • About Us
Home News Equities

Reckitt Benckiser Beats Profit Expectations Despite Sales Decline, Eyes Modest Growth in 2025

by Team Lumida
March 6, 2025
in Equities
Reading Time: 3 mins read
A A
0
Reckitt Benckiser Beats Profit Expectations Despite Sales Decline, Eyes Modest Growth in 2025
Share on TelegramShare on TwitterShare on FacebookShare on LinkedinShare on Whatsapp

Key Takeaways:

Powered by lumidawealth.com

  • Reckitt Benckiser’s adjusted operating profit for 2024 exceeded market expectations at £3.475 billion, despite a 3% decline in revenue.
  • Revenue fell to £14.17 billion, missing consensus estimates, with strong growth in hygiene offset by a 7.3% decline in the nutrition segment.
  • The company’s turnaround efforts are progressing, with restructuring costs and impairments impacting pretax profit, which dropped to £2.10 billion.
  • Reckitt forecasts 2%-4% revenue growth in 2025, with performance expected to be stronger in the second half of the year.

What Happened?

Reckitt Benckiser, the maker of brands like Lysol, Dettol, and Durex, reported better-than-expected adjusted operating profit of £3.475 billion for 2024, surpassing market consensus of £3.31 billion. However, revenue declined by 3% to £14.17 billion, missing expectations of £14.19 billion. The hygiene segment grew 4.2% on a like-for-like basis, while the nutrition segment saw a 7.3% revenue drop. Pretax profit fell to £2.10 billion, down from £2.40 billion in 2023, due to higher one-off impairments and restructuring costs.

Why It Matters?

Reckitt’s performance highlights the company’s ability to deliver profitability despite revenue challenges, reflecting progress in its turnaround strategy. The strong growth in the hygiene segment underscores the resilience of its core brands like Lysol and Dettol, even as the nutrition segment faces headwinds. For investors, the company’s ability to beat profit expectations despite restructuring costs signals operational efficiency and cost management. However, the revenue decline and uneven segment performance indicate areas of concern, particularly in nutrition.

What’s Next?

Reckitt expects group revenue growth of 2%-4% in 2025, with performance likely to be weighted toward the second half of the year. The company plans to focus on its Essential Home and Mead Johnson Nutrition segments to drive growth. Investors should monitor the impact of restructuring efforts, potential recovery in the nutrition segment, and the company’s ability to sustain growth in its hygiene business. Reckitt’s ability to navigate cost pressures and deliver on its growth forecast will be key to its long-term success.

Source
Previous Post

Homebuilder Stocks Present Opportunity Amid Market Uncertainty and Pullback

Next Post

Bitcoin Could Swing $5K After White House Crypto Summit, ETH and SOL Volatility Expected

Recommended For You

PepsiCo Reverses Chip Price Cuts After 15% Reductions Produced a 2% Revenue Decline and Flat Volume

by Team Lumida
2 hours ago
Private Equity Turns to Financial Engineering; CFO Issuance by Secondaries Funds Soars to $6.5B in 2025 From $400M in 2021

Dip prices are rising as much as 13.6% at Dollar General, well above the low-to-mid single digit increase the company describes for chips.

Read more

VW’s Restructuring Truce ‘Fragile’; Profit Warning + Euro Stoxx Ejection Same Week; 50,000 Job Cuts Approved; Four German Factories at Risk; Blume Used Legal Workaround to Override Union/State

by Team Lumida
9 hours ago
VW’s Restructuring Truce ‘Fragile’; Profit Warning + Euro Stoxx Ejection Same Week; 50,000 Job Cuts Approved; Four German Factories at Risk; Blume Used Legal Workaround to Override Union/State

FT opinion: VW's supervisory board approved painful restructuring but governance truce between management/workers/Lower Saxony is fragile. Blume threatened legal workaround to bypass union/state influence. Profit warning + Euro...

Read more

Apple-OpenAI Partnership Collapsed: ChatGPT Integration ‘Dramatically Underperformed’; Apple Pivoted to Google Gemini Siri AI; Court Documents Reveal Breakdown; xAI Antitrust Case Resolved

by Team Lumida
9 hours ago
Apple-OpenAI Partnership Collapsed: ChatGPT Integration ‘Dramatically Underperformed’; Apple Pivoted to Google Gemini Siri AI; Court Documents Reveal Breakdown; xAI Antitrust Case Resolved

Court filings reveal OpenAI's ChatGPT integration on iPhones 'dramatically underperformed' after 2024 launch. Default 'off' setting caused poor uptake. Apple pivoted to Google Gemini for Siri AI instead....

Read more

Jana Presses Six Flags to Hire Bankers for a Sale With the Stock Down 45% and Market Value at $1.3 Billion

by Team Lumida
1 day ago
Financials Index Falls 2.4% to a July Low as Muse Turns AI Into a Threat to Companies That Profit From Customer Friction

The activist wants a strategic review after a 7% revenue decline, but pending brain-injury litigation complicates any sale process.

Read more

Goldman-Linked Oncoclinicas Implodes in Brazilian Governance Crisis; $990M Debt Restructuring; Banco Master Exposure; Two Goldman Employees Named Fraud Suspects

by Team Lumida
1 day ago
Goldman-Linked Oncoclinicas Implodes in Brazilian Governance Crisis; $990M Debt Restructuring; Banco Master Exposure; Two Goldman Employees Named Fraud Suspects

Oncoclinicas cancer treatment provider collapses under debt burden, governance disputes (Goldman/Centaurus ownership), and Banco Master fraud exposure. IPO 2021 at $1.87B, now down 85%. Patient care disrupted; lawsuits...

Read more

Financials Index Falls 2.4% to a July Low as Muse Turns AI Into a Threat to Companies That Profit From Customer Friction

by Team Lumida
2 days ago
Financials Index Falls 2.4% to a July Low as Muse Turns AI Into a Threat to Companies That Profit From Customer Friction

Banks, insurers and booking sites sold off on fears that personal AI agents will end the consumer inertia their margins depend on.

Read more

SoFi Becomes the First Fintech Bank in the US Top 50 With $46.8 Billion in Deposits as Bank Count Falls to 4,249

by Team Lumida
2 days ago
SoFi Becomes the First Fintech Bank in the US Top 50 With $46.8 Billion in Deposits as Bank Count Falls to 4,249

Banks above $10 billion added 1,091 branches while everyone else shed 1,329, and the same threshold is shaping opposite fintech strategies.

Read more

Westinghouse Electric $50B IPO Signals US Nuclear Renaissance; Trump ‘National Champion’ Positioning, $80B Government Funding, AP1000 Monopoly, Duke Energy Customer

by Team Lumida
2 days ago
Westinghouse Electric $50B IPO Signals US Nuclear Renaissance; Trump ‘National Champion’ Positioning, $80B Government Funding, AP1000 Monopoly, Duke Energy Customer

Westinghouse (51% Brookfield, 49% Cameco) filing $50B IPO valued at 55x trailing EBITDA. Trump government backing $80B new reactor buildout, AP1000 only NRC-certified large design; SMR startups pressured.

Read more

RBC Downgrades LVMH, Burberry; Slashes 2027 EPS for Kering, Moncler, Hermes, Swatch; Luxury Sector on Course for Worst Year Since 2008 (-15%)

by Team Lumida
2 days ago
RBC Downgrades LVMH, Burberry; Slashes 2027 EPS for Kering, Moncler, Hermes, Swatch; Luxury Sector on Course for Worst Year Since 2008 (-15%)

RBC analysts cut luxury stock ratings citing overly optimistic 2027 earnings expectations. China demand softening, US spending potentially moderating, inflation pressures threaten margin expansion assumptions.

Read more

Nvidia Flashes Valuation Warning Sign; Trading <17x Earnings (Lowest 10+ Years) Despite 90% FY2027 Revenue Growth; Competitive In-House Chip Threat

by Team Lumida
2 days ago
Nvidia’s Stock: Is It Too Good to Be True Now?

NVDA PE ratio compressed to

Read more
Next Post
a group of rings

Bitcoin Could Swing $5K After White House Crypto Summit, ETH and SOL Volatility Expected

Premium Chinese Brands: Why Investors Are Losing Faith

China Sets Ambitious Growth Target for 2025, Prepares Stimulus Amid U.S. Tariff Pressures

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Related News

Tech Titans Pivot: Silicon Valley’s New Alliance in Trump’s Second Term

Trump’s Day-One Tariff Shifts Signal Economic Policy Volatility Ahead

January 21, 2025
US and Iran Trade Heaviest Fire in Months — Ballistic Missiles, Kuwait Airport Hit as Ceasefire Frays

Iran Fires Ballistic Missiles at Hormuz Shipping as U.S. Holds Back — and Arab Allies Grow Frustrated

August 19, 2026
Bitcoin Plunges to $64K Amid U.S. Tech Stock Turmoil

Trump-Backed Crypto Venture Seeks U.S. Bank Charter for Stablecoin Expansion

January 8, 2026

Subscribe to Lumida Ledger

Browse by Category

  • Lifestyle
    • Family Office
    • Health and Longevity
    • Legacy
    • Next Gen Wealth
    • Trust, Tax, and Estate
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Latest
    • Macro
    • Markets
    • Real Estate
  • Opinions
    • Investing Philosophy
    • Op-Ed
  • Research
    • Trackers
  • Themes
    • Aging & Longevity
    • AI
    • Biotech
    • CRE
    • Cybersecurity
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
    • Software
Facebook Twitter Instagram Youtube TikTok LinkedIn
Lumida News

Premium insights to help you invest beyond the ordinary. Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser

CATEGORIES

  • Aging & Longevity
  • AI
  • Alt Assets
  • Biotech
  • CRE
  • Crypto
  • Cybersecurity
  • Digital Assets
  • Equities
  • Family Office
  • Health and Longevity
  • Investing Philosophy
  • Latest
  • Legacy
  • Legacy Brands
  • Lifestyle
  • Macro
  • Markets
  • News
  • Next Gen Wealth
  • Nuclear Renaissance
  • Op-Ed
  • Private Credit
  • Real Estate
  • Software
  • Themes
  • Trackers
  • Trust, Tax, and Estate

BROWSE BY TAG

AI AI chips Amazon Apple Artificial Intelligence Banking Bitcoin China Commercial Real Estate CPI Crypto data centers Donald Trump EARNINGS ELON MUSK ETF Ethereum Federal Reserve financial services generative AI Goldman Sachs Google India Inflation Intel Interest Rates Investment Strategy Japan Jerome Powell JPMorgan Markets Meta Microsoft Nasdaq Nvidia OpenAI private equity S&P 500 SEC stock market Tech Stocks tesla Trump Wells Fargo Whale Watch

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018

No Result
View All Result
  • Home
  • Earnings
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018